Sabra Health Care REIT's Valuation: Undervalued by 60.5% According to DCF Analysis

Sabra Health Care REIT has experienced a 15.6% return over the past year and a 80.0% return over three years. Its recent share price of $18.84 has been valued using a discounted cash flow analysis, which suggests the stock is undervalued by 60.5%. The company's 5 out of 6 valuation score indicates that it may be a good investment opportunity for those looking for value in the healthcare real estate and senior housing sector.